Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data

Go back to Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data
(NASDAQ: RXRX) Delayed: 3.28 -0.07 (2.09%)
Previous Close $3.35    52 Week High
Open $3.37    52 Week Low
Day High $3.38    P/E N/A 
Day Low $3.26    EPS
Volume 6,527,165